文献速递产科生殖医学

围受孕期母体一碳生物标志物与根据Carnegie分期的胚胎发育相关

Periconceptional maternal one-carbon biomarkers are associated with embryonic development according to the Carnegie stages.
PubMed 文献 · Hum Reprod · 2017-01-01

前瞻性围受孕期队列研究纳入234例单胎持续妊娠,纵向三维超声评估Carnegie分期。血清维生素B12与胚胎发育正相关,红细胞叶酸仅在IVF/ICSI妊娠中正相关,血浆总同型半胱氨酸负相关。

要点

  • 血清维生素B12与胚胎发育正相关,低浓度组较高浓度组发育延迟1.4天。
  • 红细胞叶酸仅在IVF/ICSI妊娠中与Carnegie分期正相关,低浓度组延迟1.8天。
  • 血浆总同型半胱氨酸与胚胎发育负相关,高浓度组较低浓度组延迟1.6天。

核心结论

  • 血清维生素B12、红细胞叶酸和血浆总同型半胱氨酸与根据Carnegie分期的胚胎发育相关。

研究设计与样本

  • 2010年至2014年纳入单胎持续妊娠的前瞻性围受孕期队列研究,共234例,包括138例严格孕龄推算的自然或IUI妊娠和96例IVF、ICSI或冻融胚胎移植妊娠。

主要发现

  • 每例妊娠中位三维超声扫描3次(范围1-5),获得600个高质量数据集用于Carnegie分期标注(80.5%)。
  • 维生素B12与胚胎发育在总研究人群中正相关(β=0.001,95%CI:0.000;0.002,P<0.05),在严格孕龄推算的自然妊娠亚组中也正相关(β=0.002,95%CI:0.001;0.003,P<0.05)。
  • 低维生素B12浓度(-2SD,73.4 pmol/l)较高浓度(+2SD,563.1 pmol/l)胚胎发育延迟1.4天(95%CI:1.3-1.4)。
  • 红细胞叶酸仅在IVF/ICSI妊娠中与Carnegie分期正相关(β=0.001,95%CI:0.0005;0.0015,P<0.05),低浓度(-2SD,875.4 nmol/l)较高浓度(+2SD,2119.9 nmol/l)发育延迟1.8天(95%CI:1.7-1.8)。
  • 总同型半胱氨酸在总研究人群中与胚胎发育负相关(β=-0.08,95%CI:-0.14;-0.02,P<0.01),在IVF/ICSI亚组中也负相关(β=-0.08,95%CI:-0.15;-0.01,P<0.05);高浓度(+2SD,10.4 µmol/l)较低浓度(-2SD,3.0 µmol/l)发育延迟1.6天(95%CI:1.5-1.7)。

临床怎么用

  • 作者认为,在围受孕期保健中,母体一碳生物标志物应作为胚胎形态发育的预测因素加以考虑。
  • 作者认为,将胚胎大小测量与形态学评估相结合可能更好地定义正常胚胎发育。

局限性

  • 研究在三级医疗中心进行,叶酸补充剂使用率和合并症比例较高,可能降低研究结果的外部有效性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is periconceptional maternal one-carbon (I-C) metabolism associated with embryonic morphological development in non-malformed ongoing pregnancies? SUMMARY ANSWER: Serum vitamin B12, red blood cell (RBC) folate and plasma total homocysteine (tHcy) are associated with embryonic development according to the Carnegie stages. WHAT IS KNOWN ALREADY: Derangements in maternal I-C metabolism affect reproductive and pregnancy outcomes, as well as future health of the offspring. STUDY DESIGN, SIZE, DURATION: Between 2010 and 2014, women with singleton ongoing pregnancies were enrolled in a prospective periconceptional cohort study. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 234 pregnancies, including 138 spontaneous or IUI pregnancies with strict pregnancy dating and 96 pregnancies derived from IVF, ICSI or cryopreserved embryo transfer (IVF/ICSI pregnancies), underwent longitudinal transvaginal three-dimensional ultrasound (3D US) scans from 6+0 up to 10+2 weeks of gestation. Carnegie stages were defined using internal and external morphologic criteria in a virtual reality system. Maternal venous blood samples were collected at enrollment for serum vitamin B12, RBC folate and plasma tHcy assessment. Associations between biomarker concentrations and longitudinal Carnegie stages were investigated using linear mixed models. MAIN RESULTS AND THE ROLE OF CHANCE: We performed a median of three 3D US scans per pregnancy (range 1-5) resulting in 600 good quality data sets for the Carnegie stage annotation (80.5%). Vitamin B12 was positively associated with embryonic development in the total study population (β = 0.001 (95% CI: 0.000; 0.002), P < 0.05) and in the subgroup of strictly dated spontaneous pregnancies (β = 0.002 (95% CI: 0.001; 0.003), P < 0.05). Low vitamin B12 concentrations (-2SD, 73.4 pmol/l) were associated with delayed embryonic development by 1.4 days (95% CI: 1.3-1.4) compared with high concentrations (+2SD, 563.1 pmol/l). RBC folate was positively associated with Carnegie stages only in IVF/ICSI pregnancies (β = 0.001 (95% CI: 0.0005; 0.0015), P < 0.05). In this group, low RBC folate concentrations (-2SD, 875.4 nmol/l) were associated with a 1.8-day delay (95% CI: 1.7-1.8) in development compared with high concentrations (+2SD, 2119.9 nmol/l). tHcy was negatively associated with embryonic development in the total study population (β = -0.08 (95% CI: -0.14; -0.02), P < 0.01), as well as in the IVF/ICSI subgroup (β = -0.08 (95% CI: -0.15; -0.01), P < 0.05). High tHcy concentrations (+2SD, 10.4 µmol/l) were associated with a delay of 1.6 days (95% CI: 1.5-1.7) in embryonic development compared with low concentrations (-2SD, 3.0 µmol/l). LIMITATIONS, REASONS FOR CAUTION: The study was performed in a tertiary care center, resulting in high rates of folic acid supplement use and comorbidity that may reduce the external validity of our findings. WIDER IMPLICATIONS OF THE FINDINGS: In periconceptional care, maternal I-C biomarkers should be taken into account as predictors of embryonic morphological development. Combining embryonic size measurements with morphological assessment could better define normal embryonic development. STUDY FUNDING/COMPETING INTEREST(S): The work was funded by the Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Centre, Rotterdam, The Netherlands. RPMST is CSO of the startup company Slimmere Zorg and CEO of eHealth Care Solutions. The authors declare no conflicts of interest. TRIAL REGISTRATION NUMBER: Not applicable.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Parisi F, Rousian M, Koning AH, et al. Periconceptional maternal one-carbon biomarkers are associated with embryonic development according to the Carnegie stages. Hum Reprod. 2017. PMID: 28104698. doi:10.1093/humrep/dew349

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。